Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1998-07-30
Original market date: See footnote 1
1993-12-31
Product name:
PROHANCE
DIN:
02016087 Electronic product monograph is not available
Company:
SQUIBB DIAGNOSTICS, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC.
2365 Cote De Liesse
Montreal
Quebec
Canada
H4N 2M7
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
36:89.00* See footnote6
Anatomical Therapeutic Chemical (ATC): See footnote 4
V08CA04 GADOTERIDOL
Active ingredient group (AIG) number:See footnote5
0124199001
Active ingredient(s) | Strength |
---|---|
GADOTERIDOL | 279.3 MG / ML |